Delivery Order SPE2DB22D3004-SPE2DB25FRS98
- Not listed
- The Defense Logistics Agency awarded a $17,257.88 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $9,806.98 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract was executed on September 16, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,168.81 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical supply delivery under AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a delivery order valued at $70,857.49 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. This firm fixed price, competitively awarded contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the open competitive procurement process through...
- The Defense Logistics Agency awarded a $10,359.88 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml syringes, with an ultimate completion date of September 16, 2025. The contract was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $9,158.68 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes, with a completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, supporting federal military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Enbrel 50 mg/mL syringes with a ceiling value of $13,602.12. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The performance location is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $19,183.16 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, effective June 2, 2025, with completion targeted for June 3, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $13,737.99 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, with an ultimate completion date of September 12, 2025. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child contract...
- The Defense Logistics Agency awarded a $22,897 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes, with performance in Conshohocken, Pennsylvania and an ultimate completion date of June 2, 2025. This is a non-set-aside, competitively awarded contract that reflects AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military and veteran healthcare systems. The award represents a child order under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRS98Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,158.68 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide, enabling the company to supply specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The current delivery order for Enbrel, a biologic immunosuppressant medication, supports federal medical procurement needs for military and veteran healthcare systems through DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 7/31/25 |